United Kingdom: New medical cannabis variety authorized for patients
Published
The United Kingdom has just authorized the prescription of a new variety of medical cannabis, named "THCV Harmony." This product is distinguished by its unique chemical composition, containing 10% THC and 7% THCV, a cannabinoid that is still not widely available on the market.
THCV, or tetrahydrocannabivarin, is a molecule that is sparking growing interest within the scientific community. Unlike traditional THC, this substance possesses different properties that could offer new therapeutic options for certain British patients suffering from chronic conditions.
Although this development directly concerns the British healthcare system, it highlights the rapid evolution of legislation surrounding medical cannabis in Europe. Many countries are closely observing these developments to better understand the clinical effects of these new varieties on human health.
In France, the issue of medical cannabis remains governed by a national experiment launched in 2021. While French authorities are closely following international research, access to products containing THCV is not yet on the agenda within the framework of this pilot program.
This news illustrates the growing diversification of cannabinoid-based treatments. It now remains to await feedback from British patients and future clinical studies to confirm the real long-term efficacy of this new variety.
Sources: Newsweed
More France news
- Maxime Pavageau, 29, wins France's best young wine seller title
- A New, Highly Promising Concrete
- Paris and Île-de-France: Immersive Exhibitions to Experience Art Differently
- France 3 broadcasts a documentary on the history of the Téléthon, narrated by Zazie
- ChatGPT launches business profiles with mention and click statistics
- Trail: France Outdoor Seeks to Frame Environmental Restrictions
- A Roanne company bets on knitwear made in France
- Sport: Major Win for the Brûleurs de Loups and Six Internationals Absent for FC Annecy